Epivir 150 mg Tablets

Epivir 150 mg Tablets and the Choice You're Making

Epivir is the brand name for lamivudine, a nucleoside reverse transcriptase inhibitor (NRTI) used with other antiretroviral medicines to treat HIV-1 infection. The concrete product in our current listing is a 150 mg oral tablet. Because we offer this product in one strength, the main purchasing decision is which available package quantity matches the amount prescribed and the timing of your next refill.

We currently list six quantities: 30, 60, 90, 120, 180, and 240 tablets. Epivir appears in our Anti Viral & Immunity category and among our HIV Treatment Options. This guide explains how to compare those quantities without treating a lower unit price as a reason to order more medicine than your treatment plan requires.

Available Packages and Unit Value

The package comparison below shows our current Epivir 150 mg options, including exact package prices, price per tablet, and relative value. It is the appropriate place to compare the commercial figures without relying on unsupported market averages or competitor prices.

A lower price per tablet can make a larger package financially efficient, but only when the quantity agrees with the prescription, expected treatment duration, refill arrangements, expiration date, and available storage. Unit value should therefore be considered alongside medical suitability rather than used as the sole basis for choosing a package.

How Many Tablets Match the Prescribed Regimen?

The usual adult dosage for HIV-1 treatment is 300 mg of lamivudine per day, given as 150 mg twice daily or 300 mg once daily, in combination with other antiretroviral medicines. When the prescribed daily dose is supplied entirely with the 150 mg tablets listed here, that generally means two tablets per day. Some people, including those with reduced kidney function, may require a different dose, so the prescription takes priority over this general comparison.

These durations are calculations, not individualized dosing instructions. Before selecting a quantity, consider:

• The number of 150 mg tablets stated on the prescription.
• How long the current combination regimen is expected to continue before clinical review.
• When the next refill can be arranged so treatment is not interrupted.
• Whether the entire quantity can be stored correctly and used before its expiration date.

Do not increase, reduce, or extend the prescribed treatment simply to fit a package size. If the available quantities do not align neatly with the prescription, confirm the appropriate amount with the prescriber or dispensing pharmacist.

Strength, Form, and Brand Identity

Every option in this listing has the same identity: brand-name Epivir containing lamivudine 150 mg in an oral tablet. The package quantities change, but the active ingredient, strength, dosage form, and route do not. Our listing does not present a liquid, injectable medicine, extended-release product, fixed-dose combination, or a different Epivir strength.

Lamivudine is the generic name of the active ingredient, while Epivir is the brand name. That relationship does not make every lamivudine product interchangeable. Products can have different strengths, formulations, approved uses, and dosing instructions. In particular, a lamivudine product intended for hepatitis B should not be substituted for Epivir in an HIV regimen without the prescriber's direction.

Where Epivir Fits Among Related Medicines

Epivir is one component of combination antiretroviral therapy and is not used alone to treat HIV-1. A prescriber selects companion medicines according to treatment history, resistance results, kidney and liver function, potential interactions, and other individual factors.

Ziagen contains abacavir, while Emtriva contains emtricitabine; these are distinct antiretroviral medicines rather than alternate brand names for lamivudine. Viread also has a role in some HIV regimens. Truvada and Descovy are fixed-dose combination tablets containing more than one active ingredient, so they differ from single-ingredient Epivir in both composition and prescribing role. Emtricitabine and lamivudine are generally not used together because of their similarities.

Vemlidy, Baraclude, and Zeffix are associated with chronic hepatitis B treatment and are not direct replacements for Epivir in an HIV-1 regimen. Although Zeffix also contains lamivudine, its indication and product specifications differ. None of these related brands are in our current catalog, and any change between antiretroviral or hepatitis B medicines requires clinical review rather than a price-only comparison.

What Is Lamivudine Used For?

Lamivudine 150 mg tablets are used with other antiretroviral agents to treat HIV-1 infection. Lamivudine also has established pediatric use from 3 months of age, but pediatric dosing is based on body weight and the child's ability to take the selected formulation. The 150 mg tablet is suitable for a child only when the prescriber determines that it can provide the required dose accurately; an oral solution may be selected when tablets are unsuitable.

Combination treatment suppresses viral replication, lowers viral load, and helps preserve immune function. Epivir is not a cure for HIV. The effect of treatment on transmission depends on achieving and maintaining viral suppression, so patients should follow the broader treatment, monitoring, and prevention plan established with their health care team.

How Lamivudine Works and How Epivir Is Taken

HIV uses an enzyme called reverse transcriptase to copy its genetic material. Lamivudine is converted inside cells to an active form that interferes with this process and helps stop the virus from making new copies. Because HIV can develop resistance, lamivudine is combined with other antiretroviral medicines that act as part of a complete regimen.

Epivir tablets are taken by mouth and may be taken with or without food. Follow the prescribed dose and schedule consistently. Do not stop Epivir, skip doses intentionally, change the number of tablets, or replace it with another antiretroviral medicine without clinical advice. If a dose is missed, follow the instructions supplied with the medicine or contact a pharmacist or prescriber; do not take an extra dose unless specifically instructed.

Running out of one component can disrupt the complete regimen. When comparing package quantities, allow enough time to arrange the next refill, but do not order beyond the amount authorized solely to obtain a lower unit price.

Safety, Interactions, and Storage

Commonly reported effects include headache, dizziness, trouble sleeping, fatigue, and feeling unwell. A person who experiences dizziness or fatigue should avoid driving or operating machinery until it is clear how the medicine affects them. Seek prompt medical advice for severe, persistent, or unexpected symptoms.

Serious warnings associated with lamivudine include lactic acidosis and severe liver enlargement with fat accumulation. People who have both HIV-1 and hepatitis B require particular care because hepatitis B can worsen after lamivudine is stopped. Epivir and lamivudine products intended specifically for hepatitis B are not interchangeable on a tablet-for-tablet basis. Kidney function is also important because reduced kidney function can require dose adjustment.

Known hypersensitivity to lamivudine or any tablet ingredient is a contraindication. Pregnancy requires individualized HIV management and monitoring; available registry data have not shown an increased risk of major birth defects. For the HIV-1 population described in the supplied product guidance, patients are instructed not to breastfeed because HIV can be transmitted through breast milk and lamivudine is present in human milk.

Tell the prescriber and pharmacist about all prescription medicines, nonprescription medicines, and supplements. Important considerations include products containing emtricitabine or another lamivudine formulation, trimethoprim-containing medicines, and medicines or solutions containing sorbitol, which may affect lamivudine exposure.

• Use Epivir only as part of the complete regimen prescribed for you.
• Do not share tablets or use another person's antiretroviral medicine.
• Store the tablets at 77°F; excursions from 59°F to 86°F are permitted.
• Keep the medicine securely stored and follow the container label for handling and expiration information.

Is a Prescription Required in the United States?

Epivir is a prescription medicine in the United States. The FDA has approved Epivir 150 mg tablets under NDA 020564 for use with other antiretroviral agents to treat HIV-1 infection. This federal regulatory status is separate from our checkout procedure.

Under our current ordering policy, we do not require a customer to upload or fax a prescription before checkout. That procedure does not change Epivir's US prescription status or replace the need for prescribing, dosing, laboratory monitoring, and regimen selection by a qualified health care professional. Package availability should not be interpreted as medical authorization to begin, continue, or alter treatment.

Ordering, Support, and Delivery

After confirming the prescribed strength and quantity, select the corresponding 150 mg tablet package and add it to the cart. Checkout displays the information needed to complete the order, including the available payment and shipping details. Enter the delivery address carefully and verify the quantity before submitting the order.

1. Confirm that the selected product is Epivir 150 mg oral tablets.
2. Choose the package quantity that corresponds to the prescribed amount.
3. Review the price and unit value shown for that package.
4. Check the order and delivery information before completing checkout.

We have operated since 2017, and our support team is available 24/7 by phone, email, and online chat for questions about package listings or the ordering process. A pharmacist is also available for medicine-related questions. Decisions about dose changes, missed-dose management, treatment duration, or switching antiretroviral medicines should be addressed with a pharmacist or the clinician managing the HIV regimen.

A Balanced Package Decision

The appropriate Epivir package is the quantity that fits the prescription and expected refill interval while remaining practical to store and use before expiration. The 30-, 60-, 90-, 120-, 180-, and 240-tablet options provide different supply lengths, but no package is automatically the right choice merely because it has the lowest price per tablet.

Begin with the prescribed number of 150 mg tablets, compare the package values shown above, and account for refill timing and storage. If a larger quantity is medically appropriate and will be used as directed, its unit value may be relevant. If the treatment plan may change or a smaller quantity is prescribed, ordering extra tablets for a lower unit cost would not represent useful value.